✦ LIBER ✦

Impact of epidermal growth factor receptor (EGFR) mutations on responsiveness of non-small cell lung cancer (NSCLC) to tyrosine kinase inhibitors (TKIs): Prospective observations

✍ Scribed by Nico van Zandwijk; Alexandre Mathy; Daphne de Jong; Paul Baas; Sjaak Burgers; Petra Nederlof

Book ID: 119233467
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 52 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/j.ejcsup.2006.04.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

Primary resistance to epidermal growth f

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

✍ Lee, J. K.; Shin, J.- Y.; Kim, S.; Lee, S.; Park, C.; Kim, J.- Y.; Koh, Y.; Keam 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 215 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI

✍ Yi, Hyeon Gyu; Kim, Hye Jin; Kim, Yu Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Ho 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Update of epidermal growth factor recept

Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer

✍ Chen, Yuh-Min 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Chinese ⚖ 720 KB

Pretreatment Epidermal Growth Factor Rec

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non-Small-Cell Lung Cancer

✍ Su, K.-Y.; Chen, H.-Y.; Li, K.-C.; Kuo, M.-L.; Yang, J. C.-H.; Chan, W.-K.; Ho, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 676 KB

Uncommon Epidermal Growth Factor Recepto

Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance

✍ Massarelli, Erminia; Johnson, Faye M.; Erickson, Heidi S.; Wistuba, Ignacio I.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 478 KB